Prevent contamination with small-scale, sterile connections for single-use R&D and PD processing
AseptiQuik® connectors from CPC provide easy and reliable sterile connections for single-use biopharmaceutical processing. Robust designs for 1/8” (3.2mm) to 1” (26.4mm) quickly transfer valuable media. Download our Q&A.
AseptiQuik® connectors from CPC make it easy to create closed bioprocessing systems for low-volume applications such as R&D and product development. With robust, easy-to-use sterile connector designs for tubing as small as 3.2mm (1/8”), our connectors enable technicians to transfer media with more confidence and reduced risk of biological contamination and cross-contamination.
For even greater flexibility in R&D settings, CPC offers combination connectors that enable easy connections between hybrid stainless steel and single-use processing. The AseptiQuik STC connector combines an AseptiQuik sterile connector with a Steam-Thru® II SIP connection that can be mounted directly to a stainless steel vessel via a sanitary termination.
CPC’s sterile connection technologies include genderless AseptiQuik connectors that simplify single-use systems design and process integration and are available in sizes ranging from 6.4mm to 19.0mm (1/4” to 3/4”). Because the connectors are interchangeable-any single-use G series connector mates with any other G series connector-systems are more flexible and minimize supply chain complexity.
The AseptiQuik family offers the broadest range of single-use sterile connectors in the industry, with flow configurations from 3.2mm to 25.4mm (1/8” to 1”). For more information on closed systems for small-scale processes, download our Q&A.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Innovative Solutions in Pre-Filled Syringes for Biologics and Ophthalmic Applications
May 5th 2025Don't miss this webinar delving into: - How to streamline the selection of the primary container and delivery device - How to overcome silicone challenges in PFSs - How to enhance the delivery of highly viscous drug formulation
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Container selection for a highly sensitive drug product: a success story
May 5th 2025For new drug products, it is essential that pharmaceutical companies utilize the experience of container suppliers as early as possible. Read this white paper and discover how Stevanato Group can support you from start to finish.
Design testing strategies to develop a drug-device combination product
May 5th 2025Commercializing a drug-device combination product is a complex challenge to handle alone. Learn how Stevanato Group’s Technology Excellence Centers can provide guidance and execution through the various steps of a Validation Master Plan.
